IngredientsBanana is the common name for herbaceous plants of the genus Musa and for the fruit they produce. Bananas (Musa spp.) are among the most consumed fruits globally, including numerous cultivated varieties and hundreds of wild species. All of them are derived from two wild species, Musa acuminata and Musa balbisiana, with genomes ranging from diploid to tetraploid. This complex hybrid, derived from Musa acuminata and Musa balbisiana, is native to Asia but widely distributed across tropical regions worldwide, particularly in South and Southeast Asia and the western tropical Pacific Ocean.
The plant family Musaceae, composed of bananas, plantains, and ornamental bananas, originally evolved in Southeast Asia and surrounding tropical and subtropical regions. The primary species of commercial relevance is Musa acuminata Colla (genome group AA), or its hybrid with Musa balbisiana Colla (Musa × paradisiaca L., genome group AAB or ABB), the latter encompassing most cooking bananas and plantains. There are as many as 200–300 cultivars existing in countries that grow them; however, only a few of them are cultivated on a large scale. There are wide variations reported in different banana cultivars for carbohydrates, proteins, phenols, β-carotene, minerals (Na, K, Ca, Mg, P, Fe, Zn, B, Cu, and Mn), and vitamin C. Breeding has been done for evolving β-carotene–rich cultivars such as the Fe'I group and FHIA hybrids.
Known for its accessibility, year-round availability, and exceptional nutritional value, the banana is often referred to as the "plant of virtues" (Kalpataru) due to its extensive applications and economic importance. Currently, bananas rank as the fourth most important food crop worldwide, with production increasing from 69 million tons (2000–2002) to over 100 million tons (2017–2019), valued at approximately USD 31 billion.
Bananas offer unique nutritional and medicinal properties, with all parts, including flesh and peel, usable in products like chips, powder, biscuits, and juice. In commerce and research, the primary preparations include:
In addition to fruit, bananas and plantains provide many cultures with medicines, beverages, fibers, edible floral parts, dyes, fuel, steam for cooking, cordage, and wrapping materials.
Banana (family Musaceae) is one of the world's most widely cultivated fruit crops and has been a staple for humanity since 600 BC. It is one of the oldest cultivated plants. Bananas are grown in nearly 130 countries.
All parts of the banana plant have medicinal applications: the flowers in bronchitis and dysentery and on ulcers; cooked flowers are given to diabetics; the astringent plant sap in cases of hysteria, epilepsy, leprosy, fevers, hemorrhages, acute dysentery and diarrhea, and it is applied on hemorrhoids, insect and other stings and bites; young leaves are placed as poultices on burns and other skin afflictions; the astringent ashes of the unripe peel and of the leaves are taken in dysentery and diarrhea and used for treating malignant ulcers; the roots are administered in digestive disorders, dysentery and other ailments; banana seed mucilage is given in cases of diarrhea in India.
The edible part of M. acuminata provides energy, vitamins, and minerals. All other parts of the plant have been used in the treatment of many diseases in traditional medicine. The rich diversity of phytochemicals present in them probably contributes to their beneficial effects, and validates the role of M. acuminata plant parts used by various tribes and ethnic groups across the geographical areas of the world.
Traditional medicine has utilized the flower to cure pneumonia, constipation, and ulcer problems. Antifungal and antibiotic principles are found in the peel and pulp of fully ripe bananas. The antibiotic acts against Mycobacteria.
Banana fruits and the different parts of the plant find diverse uses in various folk practices, customs, religious rituals, and medicine among villagers and tribal communities, which are oral in tradition. In South and Southeast Asia, including Assam and Bengal in Northeast India, the banana plant has held sacred significance in religious ceremonies, in addition to its culinary and therapeutic roles. Many types of phytosterols have also been reported in banana which includes stigmasterol and sitosterol.
One serving, or one medium ripe banana, provides about 110 calories, 0 gram fat, 1 gram protein, 28 grams carbohydrate, 15 grams sugar (naturally occurring), 3 grams fiber, and 450 mg potassium. One medium banana (~118 g) contains a mixture of glucose (5.9 g), fructose (5.7 g), and sucrose (2.8 g).
Banana cultivars exhibit considerable variation in nutritional and physicochemical properties. The starch-to-sugar content of bananas can change depending on the relative ripeness of the fruit. Unripe bananas are rich in resistant starch (RS), which converts progressively to free sugars as the fruit ripens.
Bananas from different species are a good source of carbohydrates, dietary fiber, proteins, polyunsaturated fatty acids, potassium, carotenoids, flavonoids, vitamin C and E, phytosterols, gallocatechin, catechin, and other polyphenols. A medium-sized banana provides good amounts of vitamin B6 and vitamin C. Aside from this, they contain small to moderate amounts of most other vitamins. Bananas also provide a moderate amount of manganese, copper, potassium, and magnesium.
Proximate analysis reveals that the flesh and peel of M. sinensis L. and M. paradisiaca L. contain substantial amounts of moisture, fiber, carbohydrates, and low fat content, while minerals K, Mg, Ca, Na, P, and N are substantially concentrated in the peels and peel extracts in particular.
Dehydrated banana inflorescences contain a particularly high content of potassium (5008.26 mg/100 g) and fiber at 49.83% (lignin, cellulose, and hemicelluloses), revealing important functional and nutritional properties.
Banana contains several bioactive compounds, such as phenolics, carotenoids, biogenic amines, and phytosterols, which are highly desirable in the diet as they exert many positive effects on human health and well-being. Phenolics present in banana fruit are the major bioactive compounds having antioxidant properties and are known for providing health benefits.
Different chemical constituents like apigenin glycosides, myricetin-3-O-rutinoside, kaempferol-3-O-rutinoside, dopamine, and serotonin have been reported in different parts and varieties of banana. Banana is a rich source of total phenols and flavanols that are considered the best way to measure the antioxidant capacity of banana.
Banana peel and pulp are rich in starch, total carotenoids, and antioxidant enzymes. β-carotene content varied from 28 µg/100 g to 117.2 µg/100 g in pulps and from 49 µg/100 g to 241.91 µg/100 g in peel in one study. Another study reported a concentration of β-carotene from 45 µg/100 g to 7124 µg/100 g in banana cultivars from Solomon Islands. Yellow- and orange-fleshed banana cultivars are known to be richer in trans-β-carotene content.
Levels of various bioactive amines, including tyramine, histamine, dopamine, serotonin, spermidine, and spermine have been detected in banana pulps. Banana pulps and peels exhibit a high content of various biogenic amines (e.g., serotonin, dopamine, and norepinephrine), and the levels of these amines can be dependent upon the banana variety.
Banana peel contains large amounts of dopamine and L-dopa, catecholamines with significant antioxidant activity. Musa sapientum has been reported to have high levels of dopamine in the pulp. Dopamine isolated from bananas was capable of improving LDL resistance to oxidation. A single meal of banana is reported to be very effective in minimizing plasma oxidative stress in a healthy individual due to the presence of various bioactive compounds, especially vitamin C and dopamine, while norepinephrine and serotonin involve in the elevation of blood pressure and inhibit gastric secretion.
It is important to note that dietary dopamine and serotonin from banana do not cross the intact blood–brain barrier; their systemic effects are therefore peripheral rather than central.
Phytosterols impart an important role in reduction of serum low-density lipoprotein cholesterol level by inhibiting the absorption of cholesterol from the small intestine by increasing its excretion.
Resistant starch type II, which is starch that escapes digestion in the small intestine due to its natural granular structure, can be found in high-amylose maize starch (HAMS), green banana starch, and raw potato starch. Besides resistant starch, bananas contain pectin, a water-soluble fiber that increases as the fruit ripens. Both resistant starch and pectin contribute to digestive health.
BanLec is a jacalin-related banana lectin that has potent anti-HIV activity through binding to glycosylated viral envelope proteins and blocking cellular entry. Banana lectin (BanLec), a high-mannose-specific lectin isolated from the fruit of bananas, and its molecularly engineered H84T variant have been shown to have antiviral activity through the inhibition of cellular attachment, viral entry, and endosomal fusion of viruses including HIV.
Potassium helps the body flush out extra sodium in the urine, and eases tension in blood vessel walls. Bananas, rich in potassium and fiber and low in sodium, are an important component of heart-healthy diets like DASH (Dietary Approaches to Stop Hypertension) that aims for about 4,700 mg dietary potassium daily.
Evidence has shown that high potassium intake can reduce blood pressure (BP), decrease the risk of developing cardiovascular disease, and mitigate the adverse effects of salt on blood pressure. The World Health Organization (WHO) recommends a potassium intake of at least 90 mmol/day (3.5 g/day) from food for adults to reduce BP and risk of cardiovascular disease, cerebrovascular events, and coronary heart disease.
Observational epidemiological studies have reported an inverse association between dietary potassium intake and BP, and clinical trials have documented that potassium supplementation reduces BP. However, not every clinical trial finds a blood pressure drop when potassium alone is added. In one randomized crossover trial in adults with early hypertension, adding potassium via fruit/vegetables or as a supplement did not significantly change 24-hour ambulatory blood pressure or vascular function over 6 weeks.
Reducing sodium intake is a fundamental priority for the non-pharmacological management of hypertension; in addition, recent guidelines increasingly emphasize the importance of increasing potassium intake, supported by robust evidence of its cardiovascular benefits. Despite this, the precise dose-dependent effect of potassium supplementation on blood pressure remains inadequately defined.
Evidence from many biomedical studies as well as epidemiologic and clinical research showed that carotenoids, flavonoids, phenolics, tocopherols, and phytosterols, usually found in the different banana species, can display different antioxidant, anti-inflammatory, and anti-atherosclerotic mechanisms.
Evidence strength: Moderate-to-strong for dietary potassium (which bananas contribute) and blood pressure reduction in the context of overall dietary patterns. Banana-specific human clinical trials on blood pressure are not robust; most evidence is extrapolated from potassium supplementation trials and observational studies.
According to the International Glycemic Index Database, ripe bananas have a low GI of 51, with slightly under-ripe bananas even lower at 42; they have a moderate GL of 13 and 11, respectively. The higher glycemic load score relative to glycemic index may be due to the higher carbohydrate content of bananas (28 grams in one medium banana versus about 19 grams in a medium apple), which increases the glycemic load.
Glycemic indices of Silk, Mysore, Gros Michel, and Pisang Awak varieties were 61 ± 5, 61 ± 6, 67 ± 7, and 69 ± 9, respectively, and can be categorized as low against white bread as the standard. A single banana of the four varieties elicited a low glycemic load. Thus, consumption of a banana from any of these varieties can be recommended as a snack for healthy or diabetic patients who are under dietary management or pharmacological drugs to regulate blood glucose responses in between meals.
A 2023 study of 17 adults with type 2 diabetes found that taking resistant starch, in the form of native banana starch, reduced fasting blood sugar and blood sugar spike. It also reduced hunger and increased feelings of fullness. Other studies have indicated that resistant starch may have beneficial effects for people with type 2 diabetes, such as improving insulin sensitivity and reducing inflammation. The role of resistant starch in type 1 diabetes is less clear.
Banana possesses antioxidants, α-amylase, and α-glucosidase inhibitory effects, and a low glycemic index — making it an appropriate dietary choice for people with diabetes.
Several studies confirmed that intake of resistant starch (RS), particularly RS1 and RS2, improves glycemic control by lowering postprandial glucose and fasting insulin levels. This effect is highly relevant for the management and prevention of type 2 diabetes and related metabolic conditions.
Evidence strength: Preliminary-to-moderate. Human evidence for green banana starch improving glycemic markers is emerging but based on small trials. GI data support consumption of ripe bananas as part of diabetes-friendly diets, but direct causal benefit of banana consumption on diabetes outcomes has not been established in large randomized controlled trials.
Resistant starch contains amylase-resistant glycans, resists digestion in the upper GI tract, and has been shown to be metabolized by colonic amylolytic bacteria such as Ruminococcus bromii. It shows promise for controlling blood glucose and insulin levels, as well as acting as a prebiotic by modulating the microbiome.
Resistant starch acts as a prebiotic, selectively stimulating the growth of beneficial gut bacteria such as Bifidobacterium, Faecalibacterium prausnitzii, and Akkermansia muciniphila. This microbial modulation enhances short-chain fatty acid (SCFA) production, particularly butyrate, which has been linked to anti-inflammatory effects, improved gut barrier function, and even modulation of systemic immune responses.
One clinical trial using a resistant starch blend from potato, banana, and apple fibers demonstrated improved gastrointestinal symptoms and favorable shifts in microbiome composition, demonstrating RS's potential in human health interventions. The exploratory microbiome evaluation demonstrated that among the 16S rRNA gene sequences most associated with the consumption of the novel resistant starch blend (RSB), two belong to taxa of notable interest to human health: Faecalibacterium and Akkermansia.
Pooled data from 7 studies involving 248 individuals revealed an association between RS consumption and an increased abundance of Ruminococcus, Agathobacter, Faecalibacterium, and Bifidobacterium. However, one meta-analysis reported no significant changes in total SCFAs or butyrate concentration following RS intervention, based on data from 4 and 3 studies, respectively.
Bananas contain water and fiber, both of which promote regularity and encourage digestive health.
Evidence strength: Preliminary-to-moderate. Most gut microbiome research involves RS blends or purified RS, not whole banana per se. Human studies are small and heterogeneous in design. Results are promising but not yet definitive for whole-food banana consumption.
One study compared the acute effect of ingesting bananas versus a 6% carbohydrate drink on 75-km cycling performance and post-exercise inflammation, oxidative stress, and innate immune function. Trained cyclists (N = 14) completed two 75-km cycling time trials (randomized, crossover) while ingesting bananas or a carbohydrate drink (0.2 g/kg carbohydrate every 15 min). Blood glucose levels and performance did not differ between bananas and the carbohydrate drink.
Bananas appear to be a unique mixture of carbohydrates, nutrients, and antioxidants that may provide good nutrition support during prolonged and intensive exercise, but published data from studies with human athletes are limited. In a randomized crossover trial, ingesting bananas had a superior effect on post-exercise recovery than a 6% carbohydrate drink in twenty professional cyclists. This result could have been due to the additional electrolytes (such as potassium) that bananas provide.
The glycemic index of bananas is 51 (low-to-medium rating), similar to grapes, mangos, pineapples, raisins, macaroni, orange juice, and honey.
Evidence strength: Preliminary. Limited human trials, mostly small crossover studies in cyclists. Bananas appear comparable to carbohydrate sport drinks for fueling endurance activity, but large RCTs are lacking.
Many of the bioactive compounds in banana have antioxidant activities and are effective in protecting the body against various oxidative stresses. Different varieties of banana vary in antioxidant properties: banana peel is more active in antioxidant activities, which is 33–36% more than full green banana. The antioxidant value of bananas described in ORAC units is 1,037 µmol TE, which is similar to kiwi fruit and orange juice.
Among the banana compounds, dopamine and noradrenaline afforded a higher antioxidant capacity than other natural antioxidants, which have significant potential to contribute to the development of pharmaceutical formulations for some disease treatment.
Evidence strength: In vitro and some in vivo (animal) evidence is strong; robust controlled human clinical trials measuring outcomes attributable specifically to banana's antioxidant activity are lacking.
Phytosterols in banana impart an important role in reduction of serum low-density lipoprotein cholesterol level by inhibiting the absorption of cholesterol from the small intestine by increasing its excretion. Resistant starch modulates bile acid metabolism, gut immune responses, and systemic inflammatory markers such as C-reactive protein and interleukins. Randomized controlled trials report reductions in LDL cholesterol and systemic inflammation with RS supplementation, suggesting benefits that extend to cardiovascular risk reduction and weight management.
Some compounds in banana play important biological roles as antioxidants or anti-atherosclerotic and cardiovascular protective substances.
Evidence strength: Preclinical evidence is substantial; human RCTs specifically testing whole banana are limited. Evidence for RS-containing interventions in lipid lowering is moderate.
Substituting a single amino acid, histidine, with threonine in banana lectin (H84T BanLec) can reduce mitogenicity and maintain its antiviral properties. It can bind to mannose N-glycans and showed antiviral properties on several high-mannose expressing viruses, like HIV-1, HIV-2, hepatitis C, and influenza A and B. BanLec H84T can inhibit both virus-like particles as well as entry and replication of the Ebola virus mini-genome in cells.
H84T BanLec is a molecularly engineered lectin cloned from bananas with broad-spectrum antiviral activity against several RNA viruses. H84T BanLec dimers bind glycoproteins containing high-mannose N-glycans on the virion envelope, blocking attachment, entry, uncoating, and spread. H84T BanLec is effective against hepatitis C virus (HCV), human immunodeficiency virus (HIV), influenza A and B viruses, and Ebola virus.
Clinical development of lectins has been stalled by the mitogenicity of many of these proteins, which is the ability to stimulate deleterious proliferation, especially of immune cells. The mitogenic and antiviral activities of banana lectin (BanLec) can be separated via a single amino acid mutation, histidine to threonine at position 84 (H84T). The resulting lectin, H84T BanLec, is virtually non-mitogenic but retains antiviral activity.
BanLec has potent anti-HIV activity through binding to glycosylated viral envelope proteins and blocking cellular entry. BanLec has been assessed for anti-MERS-CoV activity in cell culture assays, and exhibits potent in vitro anti-MERS-CoV activity.
Evidence strength: Preclinical and in vitro only. All BanLec antiviral research is at the cell-culture and animal model stage. No human clinical trials for BanLec have been completed. This is an active area of pharmaceutical research rather than a demonstrated dietary benefit of eating bananas.
Certain banana cultivars rich in provitamin A carotenoids can be grown and consumed by the poor population of the world that is having serious vitamin A deficiency, and the consumption of such banana fruit would alleviate vitamin A deficiency. Consumption of fruits rich in carotenoids is reported to boost immunity and reduce the risk of various diseases, such as cancer, type II diabetes, and cardiovascular problems.
Evidence strength: Observational and epidemiological. The specific role of banana-derived carotenoids in alleviating vitamin A deficiency in human populations is plausible but not confirmed by large interventional trials.
Bananas exhibit antibacterial, antiviral, antihyperlipidemic, antiatherosclerotic, hepatoprotective, hair-growing, wound-healing, and antihypertensive properties. Peel and stalk extract of banana (M. paradisiaca) exhibited antifungal actions, and the activities were studied using the percentage inhibition test.
BanLec has potential applications based on immunomodulatory, antiproliferative, and antiviral/antimicrobial activities. However, due to the low yield of BanLec from their sources when conventional methods of isolation are employed, BanLec does not find its application in industrial settings.
Evidence strength: Largely in vitro or preclinical. Clinical human evidence for banana's antimicrobial therapeutic effects is absent.
Banana is consumed primarily as a whole food; dosing in research is often expressed in terms of serving size or isolated extract quantity.
No established official therapeutic dosage for banana as a dietary supplement exists in pharmacopoeial monographs (WHO, USP, European Pharmacopoeia). Dosages reported are from individual studies and should not be generalized.
The antinutrients alkaloid, oxalate, saponin, and phytate were detected in banana (both M. sinensis and M. paradisiaca) in safe amounts according to the World Health Organization (WHO). Ripe bananas are generally recognized as safe when consumed as food. Adverse effects from normal dietary consumption are rare in the general population.
Renin-angiotensin system inhibitors increase plasma potassium levels due to a reduction in aldosterone activity. Foods rich in potassium such as oranges and bananas may cause hyperkalemia resulting in cardiac arrest and death due to myocardial arrhythmia in patients on these drugs.
Spironolactone, a potassium-sparing diuretic, in combination with foods high in potassium, could result in hyperkalemia. Bananas are among the foods high in potassium of concern in this context. According to the FDA, people taking ACE inhibitors or ARBs may develop hyperkalemia and dangerous heart palpitations if they over-indulge in potassium-rich foods. This risk is increased for elders who have impaired kidney function.
Patients taking monoamine oxidase inhibitors (MAOIs) should be educated on the interaction between these drugs and tyramine-containing foods and beverages. Phenelzine, tranylcypromine, and isocarboxazid are among MAOI drugs. The combination of MAOI and tyramine-containing foods could result in severe hypertension. Bananas, raisins, wine, and beer are among the tyramine-containing foods and beverages. The tyramine content of foods and beverages usually increases as the ripening process occurs.
MAOIs, used to treat depression, inhibit the breakdown of endogenous and dietary amines. Consequently, MAOIs reduce the breakdown of tyramine, a precursor of catecholamines (endogenous vasoconstrictors), and raise catecholamine biosynthesis causing a hypertensive crisis. Very ripe bananas are among foods that are high in tyramine which require caution in patients on MAOIs.
Wild-type BanLec was found to be a T-cell mitogen and activated basophils and mast cells. This is relevant to pharmaceutical development of BanLec as a drug candidate, not to standard dietary consumption of banana fruit, where BanLec concentrations and oral bioavailability as an intact protein are negligible.
Research findings revealed that the Saro cultivar of Musa acuminata was nephrotoxic in an animal study, suggesting that cultivar choice matters and that not all preparations are equivalent in safety. This finding was observed in a rodent model; clinical significance for humans consuming standard commercial cultivars has not been established.
The antinutrients alkaloid, oxalate, saponin, and phytate were detected in safe amounts in both Musa sinensis and Musa paradisiaca according to WHO standards. At typical dietary intake levels, these antinutrients are not considered clinically significant.
Health conditions that Banana may help support.
Green banana resistant starch and fiber reduce abdominal discomfort symptoms including bloating, gas, and general GI distress in clinical studies. RCT evidence shows that resistant starch blends containing green banana flour ameliorate constipation, gas, bloating, and diarrhea. Traditional use of unripe banana for stomach upset is also documented.
Bananas contain diverse antioxidants including dopamine, catechins, vitamin C, carotenoids, and flavonoids. A 2008 human clinical study demonstrated that banana consumption prevents plasma oxidative stress in healthy individuals. Multiple Nieman exercise RCTs confirmed that banana metabolites augment antioxidant capacity (FRAP) during exercise and reduce exercise-induced oxidative stress markers.
Bananas contain tryptophan, vitamin B6, magnesium, and zinc—nutrients linked to serotonin synthesis and anxiety modulation. A comprehensive review of 18 studies found most experimental trials reported positive antianxiety effects, though clinical trial results were inconsistent. Vitamin B6, found abundantly in bananas, has shown anxiolytic effects in at least one RCT.
Bananas contain carotenoids, flavonoids, phenolics, and phytosterols shown to have anti-atherosclerotic and cardioprotective effects in biomedical and epidemiologic research. Banana polyphenols such as quercetin and catechin inhibit platelet aggregation and protect arterial endothelium by reducing oxidative stress. Lutein from bananas is associated with reduced LDL oxidation and atherosclerotic plaque progression.
Multiple Appalachian State University RCTs demonstrated that banana ingestion during prolonged cycling matched carbohydrate sport drinks for performance and post-exercise inflammation. Banana metabolites inhibit COX-2 mRNA expression, suggesting an anti-inflammatory effect analogous to ibuprofen. Bananas also augment antioxidant capacity during exercise through unique phenolics.
Banana is one of the most evidence-supported dietary sources of potassium for blood pressure reduction. The SSaSS cohort study (n=20,995, 5 years) linked increased potassium intake to significant reductions in blood pressure and cardiovascular events. Potassium from banana inhibits renin-angiotensin-aldosterone activity and reduces sodium reabsorption.
Green/unripe bananas are rich in resistant starch and have a low glycemic index (GI ~47), which moderates postprandial glucose and insulin responses. Native banana starch (NBS) supplementation in clinical trials improved insulin sensitivity and reduced fasting glycemia in obese and diabetic subjects. Ripeness markedly affects glycemic impact.
Banana dietary fiber—particularly soluble pectin in ripe fruit and resistant starch in green fruit—has been linked to LDL cholesterol reduction through bile acid sequestration. Animal studies confirm banana's cholesterol-lowering effect via dietary fiber. Epidemiologic reviews show high-fiber diets are consistently associated with lower LDL and reduced cardiovascular risk.
Green banana products supply resistant starch and soluble fiber that improve bowel movement frequency and stool consistency. RCT evidence shows that resistant starch blends containing green banana flour reduce constipation scores. A 2024 clinical study of green banana and pineapple fiber powder found improved bowel movement frequency after just one week.
Bananas contain tryptophan, vitamin B6, magnesium, potassium, and iron—nutrients associated with serotonergic function and depressive symptom relief. A 2019 cross-sectional Chinese study investigated the association between banana consumption and depressive symptoms in a general adult population. A comprehensive review of 18 studies found most experimental trials reported positive antidepressant effects, though clinical trial results were mixed.
Green banana is one of the best-documented natural interventions for persistent childhood diarrhea. RCTs in Bangladeshi children showed green banana or pectin reduced stool output and duration of diarrhea. Green banana resistant starch also reduces intestinal permeability and fluid loss, and improves bowel consistency in adults.
A medium banana provides approximately 422–467 mg potassium, 34 mg magnesium, and 37 mg calcium—three of the four primary electrolytes involved in cellular fluid balance and muscle contraction. Potassium from dietary sources including bananas is recognized by WHO, AHA, and international hypertension guidelines as a key dietary mineral for electrolyte and fluid regulation.
Bananas provide readily available carbohydrates (22–27 g per medium fruit), vitamin B6, and a range of electrolytes that support physical and cognitive energy. Multiple RCTs confirm banana carbohydrates sustain cycling performance comparably to commercial sports drinks over 75-km time trials. The carbohydrate-to-fiber ratio shifts with ripeness, affecting the rate of energy release.
Green banana resistant starch acts as a prebiotic, selectively promoting Bifidobacterium and Akkermansia growth in clinical studies. A 2024 RCT showed green banana powder significantly altered gut microbiome composition and improved bowel movement frequency. Fermentation of banana resistant starch by colonic bacteria produces short-chain fatty acids supporting intestinal barrier integrity.
Native banana starch supplementation at 24 g/day for 4 weeks significantly reduced body weight in obese type 2 diabetic women in a controlled trial. Green banana products are also associated with weight control benefits in the 2019 systematic review of 18 studies. Banana's resistant starch and soluble fiber increase satiety and slow gastric emptying.
Bananas support heart health primarily through potassium, dietary fiber, and antioxidant polyphenols. Potassium intake from sources like bananas is associated with reduced stroke risk and cardiovascular events in large cohort studies. Banana fiber reduces LDL cholesterol and cardiovascular risk, and banana polyphenols exhibit anti-atherosclerotic properties.
Banana fiber—particularly the soluble pectin and resistant starch in unripe forms—has demonstrated benefits on IBS-related symptoms including constipation, diarrhea, and abdominal discomfort in RCT-level evidence. A 2022 RCT of a resistant starch blend including green banana flour improved multiple GI symptoms relevant to IBS. Evidence for banana as a standalone IBS intervention is limited but the fiber-based mechanism is clinically recognized.
Native banana starch supplementation significantly improved insulin sensitivity in obese type 2 diabetic women (24 g/day, 4 weeks RCT) and in non-diabetic obese women (30 g/day, 8 weeks). The mechanism involves resistant starch slowing glucose absorption, reducing postprandial insulin demand, and promoting favorable gut microbiome changes. Green banana products were identified as a key area of study in the 2019 systematic review specifically for glycemic/insulin metabolism benefits.
Banana's potassium content supports kidney function by suppressing urinary calcium excretion, reducing the risk of kidney stones. Epidemiologic data from a Swedish prospective cohort study of 61,000 women support this association. Green banana products have also shown benefits for renal complications related to diabetes in clinical studies.
Banana's potassium content suppresses urinary calcium excretion, reducing the risk of calcium oxalate kidney stone formation. A Swedish prospective cohort study (61,000 women, 13.4 years) supported this association. Dietary potassium intake from sources like bananas is recognized as a modifiable protective factor against kidney stones.
Green banana products have shown clinical benefits across multiple components of metabolic syndrome including insulin resistance, body weight, blood pressure, and glycemia. The 2019 systematic review of 18 green banana clinical studies confirmed these benefits. Native banana starch improved insulin sensitivity and weight in obese diabetic subjects in controlled trials.
Bananas are widely used for muscle cramp relief due to their potassium, magnesium, and calcium content. However, clinical evidence specifically for exercise-associated muscle cramps (EAMC) is weak—two Ironman triathlete studies found no association between electrolyte levels and EAMC. Evidence for general (non-exercise-related) cramps caused by electrolyte deficiency is better supported.
Bananas—especially unripe varieties—are both a traditional remedy for peptic ulcers and supported by in vivo and in vitro evidence showing gastroprotective effects. Leucocyanidin from unripe banana significantly increases gastric mucosal thickness and promotes re-epithelialization in animal models. Green banana has long been traditionally used in South India and Sudan for peptic ulcer dietary management.
Ripe banana contains amylase and other endogenous enzymes that contribute to self-digestion of starch during ripening and may support digestive processes when consumed. Traditional use of banana as an easily digestible, enzyme-rich food for gastric complaints and convalescence is well documented across multiple cultures.
Banana and plantain have been used traditionally across South Asia and Africa to treat gastritis and gastric irritation, with unripe banana considered especially beneficial. In vivo and phytochemical studies confirm that banana flavonoids—particularly leucocyanidin—enhance gastric mucosal thickness and promote re-epithelialization, providing a plausible gastroprotective mechanism. Direct human RCT evidence for gastritis specifically is lacking.
Banana is a traditional component of the BRAT diet (Banana, Rice, Applesauce, Toast) used for nausea, vomiting, and gastrointestinal upset across many cultures. Its bland, easily digestible carbohydrate content and mild astringency make it a widely recommended food during episodes of nausea. Documented traditional and clinical dietary use exists, but controlled trials for nausea specifically are absent.
Body systems that Banana may help support.
Go back